Trial Profile
Levosimendan Versus Dobutamine in Cardiopathic Patients Undergoing Major Non Cardiac Surgery
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary) ; Dobutamine
- Indications Cardiovascular disorders
- Focus Therapeutic Use
- Acronyms levodobu
- 01 Jan 2014 New trial record